Synthesis and evaluation of a classical 2,4-diamino-5-substituted-furo[2,3-d]pyrimidine and a 2-amino-4-oxo-6-substituted-pyrrolo[2,3-d]pyrimidine as antifolates

被引:25
作者
Gangjee, Aleem
Yang, Jie
McGuire, John J.
Kisliuk, Roy L.
机构
[1] Duquesne Univ, Grad Sch Pharmaceut Sci, Div Med Chem, Pittsburgh, PA 15282 USA
[2] Roswell Pk Canc Inst, Grace Canc Drug Ctr, Buffalo, NY 14263 USA
[3] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA
关键词
pyrrolo[2,3-d]pyrimidines; antifolates; dihydrofolate reductase;
D O I
10.1016/j.bmc.2006.08.029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Two classical antifolates, a 2,4-diamino-5-substituted furo[2,3-d]pyrimidine and a 2-amino-4-oxo-6-substituted pyrrolo[2,3-d]pyrimidine, were synthesized as potential inhibitors of dihydrofolate reductase (DHFR) and thymidylate synthase (TS). The syntheses were accomplished by condensation of 2,6-diamino-3(H)-4-oxo-pyrimidine with alpha-chloro-ketone 21 to afford two key intermediates 23 and 24, followed by hydrolysis, coupling with L-glutamate diethyl ester and saponification of the diethyl ester to afford the classical antifolates 13 and 14. Compounds 13 and 14 with a single carbon atom bridge are both substrates for folylpoly,gamma-glutamate synthetase (FPGS), the enzyme responsible for forming critical poly-gamma-glutamate antifolate metabolites with increased potency and/or increased cell retention. Compound 14 is a highly efficient FPGS substrate demonstrating that 2,4-diamino-5-substituted furo[2,3-d]pyrimidines are important lead structures for the design of antifolates with FPGS substrate activity. It retains inhibitory potency for DHFR and TS compared to the two atom bridged analog 5. Compound 13 is a poor inhibitor of purified DHFR and TS, and both 13 and 14 are poor inhibitors of the growth of CCRF-CEM human leukemia cells in culture, indicating that single carbon bridged compounds in these series though conducive to FPGS substrate activity were not potent inhibitors. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:8590 / 8598
页数:9
相关论文
共 34 条
[1]
Pyrrolo[2,3-d]pyrimidine thymidylate synthase inhibitors:: Design and synthesis of one-carbon bridge derivatives [J].
Aso, K ;
Imai, Y ;
Yukishige, K ;
Ootsu, K ;
Akimoto, H .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (10) :1280-1287
[2]
PREPARATION OF 7-OXAAPORPHINE DERIVATIVES AND EVALUATION OF THEIR DOPAMINERGIC ACTIVITY [J].
BANZATTI, C ;
CARFAGNA, N ;
COMMISSO, R ;
HEIDEMPERGHER, F ;
PEGRASSI, L ;
MELLONI, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (07) :1466-1471
[3]
BARREDO J, 1992, MOL PHARMACOL, V42, P687
[4]
Blakley R. L., 1969, BIOCH FOLIC ACID REL, P569
[5]
CARRERAS CW, 1975, ANNU REV BIOCHEM, V64, P721
[6]
AN ANNULATION METHOD FOR THE SYNTHESIS OF HIGHLY SUBSTITUTED POLYCYCLIC AROMATIC AND HETEROAROMATIC-COMPOUNDS [J].
DANHEISER, RL ;
BRISBOIS, RG ;
KOWALCZYK, JJ ;
MILLER, RF .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (08) :3093-3100
[7]
SYNTHESIS OF 10-DEAZAPTEROIC AND 11-DEAZAHOMOPTEROIC ACIDS [J].
DEGRAW, JI ;
TSAKOTEL.P ;
KISLIUK, RL ;
GAUMONT, Y .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1971, 8 (01) :105-&
[8]
FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO
[9]
2-J
[10]
Gangjee A, 1996, CURR PHARM DESIGN, V2, P263